174 related articles for article (PubMed ID: 16714754)
41. Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: report of two cases and review of the literature.
Schaffer JV; Orlow SJ
Dermatology; 2011; 223(2):97-103. PubMed ID: 22024645
[TBL] [Abstract][Full Text] [Related]
42. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them.
Itoh T; Linn S; Ono T; Yamaizumi M
J Invest Dermatol; 2000 May; 114(5):1022-9. PubMed ID: 10771487
[TBL] [Abstract][Full Text] [Related]
43. A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype.
Badie C; Goodhardt M; Waugh A; Doyen N; Foray N; Calsou P; Singleton B; Gell D; Salles B; Jeggo P; Arlett CF; Malaise EP
Cancer Res; 1997 Oct; 57(20):4600-7. PubMed ID: 9377575
[TBL] [Abstract][Full Text] [Related]
44. Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5.
O'Donovan A; Wood RD
Nature; 1993 May; 363(6425):185-8. PubMed ID: 8483505
[TBL] [Abstract][Full Text] [Related]
45. Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site.
Keijzer W; Mulder MP; Langeveld JC; Smit EM; Bos JL; Bootsma D; Hoeijmakers JH
Cancer Res; 1989 Mar; 49(5):1229-35. PubMed ID: 2645048
[TBL] [Abstract][Full Text] [Related]
46. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.
Wei Q; Spitz MR; Gu J; Cheng L; Xu X; Strom SS; Kripke ML; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):199-204. PubMed ID: 8833620
[TBL] [Abstract][Full Text] [Related]
47. Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes.
Terunuma A; Ye J; Emmert S; Khan SG; Kraemer KH; Vogel JC
Gene Ther; 2004 Dec; 11(23):1729-34. PubMed ID: 15334113
[TBL] [Abstract][Full Text] [Related]
48. An antisense construct of full-length human RAD50 cDNA confers sensitivity to ionizing radiation and alkylating agents on human cell lines.
Kim YC; Koh JT; Shin BA; Ahn KY; Choi BK; Kim CG; Kim KK
Radiat Res; 2002 Jan; 157(1):19-25. PubMed ID: 11754637
[TBL] [Abstract][Full Text] [Related]
49. Whole-exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity.
Sugaya M; Funamizu K; Kono M; Okuno Y; Kondo T; Ono R; Akiyama M; Nishigori C; Sato S
J Dermatol; 2021 Jan; 48(1):96-100. PubMed ID: 32974964
[TBL] [Abstract][Full Text] [Related]
50. Isolation by polymerase chain reaction of a cDNA whose product partially complements the ultraviolet sensitivity of xeroderma pigmentosum group C cells.
Teitz T; Penner M; Eli D; Stark M; Bakhanashvili M; Naiman T; Canaani D
Gene; 1990 Mar; 87(2):295-8. PubMed ID: 2332174
[TBL] [Abstract][Full Text] [Related]
51. New functions of XPC in the protection of human skin cells from oxidative damage.
D'Errico M; Parlanti E; Teson M; de Jesus BM; Degan P; Calcagnile A; Jaruga P; Bjørås M; Crescenzi M; Pedrini AM; Egly JM; Zambruno G; Stefanini M; Dizdaroglu M; Dogliotti E
EMBO J; 2006 Sep; 25(18):4305-15. PubMed ID: 16957781
[TBL] [Abstract][Full Text] [Related]
52. Defective repair of gamma-ray induced DNA damage in xeroderma pigmentosum cells.
Setlow RB; Faulcon FM; Regan JD
Int J Radiat Biol Relat Stud Phys Chem Med; 1976 Feb; 29(2):125-36. PubMed ID: 1083379
[TBL] [Abstract][Full Text] [Related]
53. Establishment of cell lines derived from ataxia telangiectasia and xeroderma pigmentosum patients with high radiation sensitivity.
Hashimoto T; Nakano Y; Owada MK; Kakunaga T; Furuyama J
Mutat Res; 1986 Sep; 166(2):215-20. PubMed ID: 3020400
[TBL] [Abstract][Full Text] [Related]
54. Differential UVC-induced gadd45 gene expression in xeroderma pigmentosum cells.
Chang HC; Tsai J; Guo YL; Huang YH; Tsai HN; Tsai PC; Huang W
Biochem Biophys Res Commun; 2003 Jun; 305(4):1109-15. PubMed ID: 12767947
[TBL] [Abstract][Full Text] [Related]
55. Radiation therapy for angiosarcoma of the scalp: treatment outcomes of total scalp irradiation with X-rays and electrons.
Hata M; Wada H; Ogino I; Omura M; Koike I; Tayama Y; Odagiri K; Kasuya T; Inoue T
Strahlenther Onkol; 2014 Oct; 190(10):899-904. PubMed ID: 24622678
[TBL] [Abstract][Full Text] [Related]
56. Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival.
Jacobelli S; Soufir N; Lacapere JJ; Regnier S; Bourillon A; Grandchamp B; Hétet G; Pham D; Palangie A; Avril MF; Dupin N; Sarasin A; Gorin I
Br J Dermatol; 2008 Sep; 159(4):968-73. PubMed ID: 18717677
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous angiosarcoma in a patient with xeroderma pigmentosum.
Arora R; Sharma A; Gupta R; Vijayaraghavan M
Indian J Pathol Microbiol; 2008; 51(4):504-6. PubMed ID: 19008576
[TBL] [Abstract][Full Text] [Related]
58. [Individual radiosensitivity and DNA repair proficiency: the value of the comet assay].
Alapetite C
Cancer Radiother; 1998; 2(5):534-40. PubMed ID: 9868398
[TBL] [Abstract][Full Text] [Related]
59. Atypical Clinical Presentation of Xeroderma Pigmentosum in a Patient Harboring a Novel Missense Mutation in the XPC Gene: The Importance of Clinical Suspicion.
Meneses M; Chavez-Bourgeois M; Badenas C; Villablanca S; Aguilera P; Bennàssar A; Alos L; Puig S; Malvehy J; Carrera C
Dermatology; 2015; 231(3):217-21. PubMed ID: 26278556
[TBL] [Abstract][Full Text] [Related]
60. Differential hypersensitivity of xeroderma pigmentosum lymphoblastoid cell lines to ultraviolet light mutagenesis.
Tatsumi K; Toyoda M; Hashimoto T; Furuyama J; Kurihara T; Inoue M; Takebe H
Carcinogenesis; 1987 Jan; 8(1):53-7. PubMed ID: 3802395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
